Cite
HARVARD Citation
Yang, Y. et al. (2022). PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Drug development research. 83 (1), pp. 64-74. [Online].